Thursday, June 06, 2019 3:26:54 PM
Why Sponsored Research?
The reasons behind companies’ seeking our coverage vary. In most cases, the firms on which we publish reports cannot attract traditional research coverage by investment banks and broker-dealers. They may wish to add to their shareholder base and overall value because they are contemplating future up-listings or are perhaps seeking to use an opportunity such as greater awareness and visibility as an opportunity to raise funds for acquisitions or working capital. In nearly all cases, we find that while management teams know their industry and can speak to their partner or customer audiences, they have difficulty presenting their company to prospective investors. This is one of our strengths, as we attempt to succinctly describe the underlying companies, their industries, where they fit in the food chain, etc. Moreover, we deem it important for the research to be presented in the proper format.
Without such reports or interviews, it is likely that the stock would languish and speculative investors would not have an opportunity to learn or potentially invest in such a company. However, given the companies’ risk profile, we endeavor to list what would be considered leading risks in the risk factors sections found in our coverage initiation reports.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM